Cell Signaling and Molecular Pathology of Retinal Diseases 2.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 25 October 2024 | Viewed by 51
Special Issue Editor
Interests: photoreceptor degeneration; retinal development; retinal gene therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The number of patients with visual impairments and blindness continues to rise year after year. Glaucoma, age-related macular degeneration (AMD), and retinitis pigmentosa (RP) are identified as the top-ranking diseases that lead to blindness. There are a variety of neurons in the retina, and visual impairment occurs when even one type of neuron degenerates. Numerous studies that investigated the mechanisms of retinal degeneration induced by diseases have contributed to the development of new types of therapies such as gene therapies and cell transplantation therapies. Therefore, an understanding of the diverse signaling molecules and signal transduction pathways of retinal degeneration is fundamental for developing therapies. The aim of this Special Issue is to summarize and enlarge the knowledge of mechanisms in retinal degeneration and protection.
Therefore, authors are invited to submit original research and review articles which address the progress and current standing of basic research in retinal degeneration.
Topics include, but are not limited to, the following:
- New aspects of the mechanisms in retinal degenerative diseases;
- Techniques for the analysis and identification of retinal diseases;
- Evaluation of new treatments in animal studies.
Prof. Dr. Hiroshi Tomita
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- retinal degeneration
- regenerative medicine
- gene therapy
- electroretinogram
- visually evoked potential
- RNA-seq
- apoptosis
- animal model
